Special Issue "Application of Nanoparticles in Cancer Therapy and Diagnosis"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 5485
Interests: cancer nanovaccines; cancer immunotherapy; targeted nanosystems; polymeric and polypeptide nanotechnology; nanotechnology approaches in diabetic wound healing; pharmaceutic technology
Interests: nanoparticles; anti-inflamamtory; anti-cancer; anti-microbials; drug delviery; biomedical engineering; 3D printing
Special Issues, Collections and Topics in MDPI journals
Special Issue in Pharmaceuticals: Development of Colon Targeted Drug Delivery System
Special Issue in International Journal of Environmental Research and Public Health: Oxidative Stress/Antioxidant Research
Special Issue in International Journal of Molecular Sciences: Frontiers in Antimicrobial Materials
Special Issue in International Journal of Molecular Sciences: Advances in Antimicrobial and Macromolecules Materials
Special Issue in International Medical Education: Challenges and Opportunities in Teaching Pharmacology in Medical School
Several studies have demonstrated that the trapping of anticancer medications in submicronic colloidal systems, such as nanoparticles, can help to regulate both the tissue and cell distribution characteristics of these treatments. The overall goal of this strategy is to improve antitumor effectiveness while minimising systemic adverse effects. Additionally, nanoparticles are useful for the targeted delivery of oligonucleotides to tumour cells. Furthermore, several types of nanoparticles have shown an intriguing ability to overcome MDR resistance, a significant issue in chemotherapy. Polymeric nanoparticles, liposomes, dendrimers, nano-shells, carbon nanotubes, superparamagnetic nanoparticles, and nucleic acid-based nanoparticles (DNA, RNA interference (RNAi), and antisense oligonucleotide (ASO)) are examples of current nanotechnology platforms used for anticancer drug delivery. Recently, nanotechnologies are also being used in combination therapeutic strategies, such as ultrasound, hyperthermia, or photodynamic therapy. Decorating nanoparticles with a molecular ligand for the 'active' targeting of cancerous cells is considered as the next step in developing better cancer targeting strategies using nanoparticles. Applying nanoparticles in imaging for cancer diagnosis could lead to early detection and, consequently, improved cancer management.
Dr. Liane Isabel Ferreira Moura
Dr. Murtaza M. Tambuwala
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tumor targeting
- decorated nanoparticles
- natural compounds
- cancer diagnostics
- 3D models
- drug resistance